Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes.
Denimal D, Bergas V, Pais-de-Barros JP, Simoneau I, Demizieux L, Passilly-Degrace P, Bouillet B, Petit JM, Rouland A, Bataille A, Duvillard L, Vergès B.
Denimal D, et al. Among authors: pais de barros jp.
Cardiovasc Diabetol. 2023 May 4;22(1):104. doi: 10.1186/s12933-023-01845-0.
Cardiovasc Diabetol. 2023.
PMID: 37143040
Free PMC article.